| Mary Walters Pierce, MS CCC SLP | |
|
921 Stokes St W, Ahoskie, NC 27910-3735 | |
| (252) 287-2728 | |
| Not Available |
| Full Name | Mary Walters Pierce |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 921 Stokes St W, Ahoskie, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275767881 | NPI | - | NPPES |
| 7413159 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Walters Pierce, MS CCC SLP 921 Stokes St W, Ahoskie, NC 27910-3735 Ph: (252) 287-2728 | Mary Walters Pierce, MS CCC SLP 921 Stokes St W, Ahoskie, NC 27910-3735 Ph: (252) 287-2728 |
News Archive
Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.
Researchers continue to search for cancer treatments that effectively destroy tumor cells while protecting surrounding healthy tissue and the body. One intriguing approach involves photoactivated drugs: an inactive precursor would be administered, then the diseased tissue could be irradiated to convert the drug into its cytotoxic form locally.
Community health centers across the country will share in $150 million in grants that Health and Human Services Secretary Kathleen Sebelius said Wednesday will help them enroll up to 3.7 million Americans in the new marketplaces this fall. HHS on Wednesday announced that 1,200 centers will get at least $59,000 each, money available through the health care law (Bunis, 7/10).
Research efforts associating scientists from the CNRS, UVSQ and INSERM within the Laboratoire END-ICAP, working in collaboration with a team from the University of Bern, has demonstrated the therapeutic potential of a new class of synthetic oligonucleotides in the treatment of Duchenne muscular dystrophy (DMD) using RNA "surgery".
› Verified 1 days ago
Jacqueline Miller Bryant, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 312 Academy St S # G, Ahoskie, NC 27910 Phone: 252-578-9078 Fax: 252-276-2218 |